It appears no script is enabled within your browser. Please enable JavaScript to use this site.
Skip header and navigation
Home
View Selections:
0
Items
Help
Print
Ramipril use in Canada: HOPE or HYPE?
https://arctichealth.org/en/permalink/ahliterature186417
Source
CMAJ. 2003 Mar 4;168(5):568-9
Publication Type
Article
Date
Mar-4-2003
More detail
Author
Louise Pilote
Author Affiliation
Division of Clinical Epidemiology, McGill University, Montreal, QC. louise.pilote@mcgill.ca
Source
CMAJ. 2003 Mar 4;168(5):568-9
Date
Mar-4-2003
Language
English
Publication Type
Article
Keywords
Aged
Angiotensin-Converting Enzyme Inhibitors - administration & dosage - pharmacokinetics - therapeutic use
Canada
Cardiovascular Diseases - etiology - prevention & control
Humans
Ramipril - administration & dosage - therapeutic use
Risk factors
Notes
Cites: Ann Intern Med. 1997 Sep 1;127(5):337-459273824
Cites: Circulation. 1998 Jun 9;97(22):2202-129631869
Cites: N Engl J Med. 2000 Jan 20;342(3):145-5310639539
Cites: JAMA. 1995 May 10;273(18):1450-67654275
Cites: CMAJ. 2003 Mar 4;168(5):553-712615747
Cites: Lancet. 2000 Dec 9;356(9246):1955-6411130523
Comment In: CMAJ. 2003 Jun 24;168(13):1646; author reply 1647-812821614
Comment In: CMAJ. 2003 Jun 24;168(13):1647; author reply 1647-812821617
Comment In: CMAJ. 2003 Jun 24;168(13):1647; author reply 1647-812821615
Comment In: CMAJ. 2003 Jun 24;168(13):1646-7; author reply 1647-812821613
Comment On: CMAJ. 2003 Mar 4;168(5):553-712615747
PubMed ID
12615751
View in PubMed
Less detail
Permalink